The American multinational medical technology Becton Dickinson, announced an investment of 56 million dollars in the State of Mexico to develop a new production line that allows it to manufacture pre-fill glass syringes, as well as to build a new stopper assembly plant for These devices.

According to the information, this investment is part of a global plan to expand and update its capacity to manufacture and produce syringe technology, as well as advanced systems for the administration of medicines, vaccines and new drugs.

Check here: Monterrey, CDMX and Tijuana at the forefront of industrial real estate demand

As indicated by Alfredo Del Mazo Maza, governor of the entity, with this action, the firm will generate 600 new jobs in the state while increasing up to 11>#/p###

its production capacity.

In the world, Becton produces nearly 3.1 billion syringes in more than five plants, of which 52% are produced at its Cuautitlán Izcalli plant, making it the largest plant in the pharmaceutical systems business on the planet.

Of interest: Logistics, electronic commerce and retailers maintain industrial demand levels in CDMX

In addition, with the new production line, it will be able to increase its share of the world market for glass syringes by 10% and meet the growing demand for vaccines.

During the announcement of the investment, it was indicated that this project will also promote scientific and technological innovation in Mexico, since it will open the door to students and strengthen health institutions.

In Solili you can consult industrial warehouses available in Toluca, Tepotzotlán and Tultitlán

Original note